Detalles de la búsqueda
1.
Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies.
Haematologica
; 103(1): 107-115, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29079599
Resultados
1 -
1
de 1
1
Próxima >
>>